OTCMKTS:HSDT

Helius Medical Technologies Stock Forecast

etoro logo Buy HSDT
*Your capital is at risk
$1.75
-0.0800 (-4.37%)
At Close: Jul 10, 2026
AI Analysis AI Analysis of HSDT AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add HSDT to Watchlist?
Some Reasons Why To Add HSDT:
  • High gross margin of 94.2%
  • Low bankruptcy risk (Altman Z-Score: 18.59)
  • Highly efficient cash conversion (100% FCF/OCF ratio)
PDF

Evaluation of Helius Medical Technologies, Inc. stock downgraded after the last trading session
(Updated on Jul 10, 2026)

Sell candidate since Jul 10, 2026

The Helius Medical Technologies, Inc. stock price fell by -4.37% on the last day (Friday, 10th Jul 2026) from $1.83 to $1.75. During the last trading day the stock fluctuated 3.76% from a day low at $1.73 to a day high of $1.80. The price has risen in 7 of the last 10 days and is up by 17.45% over the past 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -217 thousand shares and in total, 146 thousand shares were bought and sold for approximately $256.12 thousand.

The stock lies the upper part of a very wide and falling trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break up at the top trend line at $1.81 will firstly indicate a slower falling rate, but may be the first sign of a trend shift. Given the current short-term trend, the stock is expected to fall -26.09% during the next 3 months and, with a 90% probability hold a price between $0.761 and $1.34 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

HSDT Signals & Forecast

The Helius Medical Technologies, Inc. stock holds a sell signal from the short-term Moving Average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. On further gains, the stock will meet resistance from the short-term Moving Average at approximately $1.78. On a fall, the stock will find some support from the long-term average at approximately $1.73. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Tuesday, July 07, 2026, and so far it has fallen -4.89%. Further fall is indicated until a new bottom pivot has been found. Volume fell along with the price during the last trading day, which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk.

Support, Risk & Stop-loss for Helius Medical Technologies, Inc. stock

On the downside, the stock finds support just below today's level from accumulated volume at $1.60 and $1.51. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Helius Medical Technologies, Inc. finds support just below today's level at $1.60. If this is broken, then the next support from accumulated volume will be at $1.51 and $1.48.

This stock may move much during the day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.0650 between high and low, or 3.76%. For the last week the stock has had daily average volatility of 5.96%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (HSDT) For The Upcoming Trading Day Of Monday 13th

For the upcoming trading day on Monday, 13th we expect Helius Medical Technologies, Inc. to open at $1.76, and during the day (based on 14 day Average True Range), to move between $1.68 and $1.82, which gives a possible trading interval of +/-$0.140 (+/-8.34%) up or down from last closing price. If Helius Medical Technologies, Inc. takes out the full calculated possible swing range there will be an estimated 8.34% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $1.60 (8.57%) than the resistance at $1.98 (13.14%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Helius Medical Technologies, Inc. stock A Buy?

Helius Medical Technologies, Inc. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Sell candidate.

Current score: -1.704 Sell Candidate Downgraded

Predicted Fair Opening Price

Predicted fair opening price on July 13, 2026 - $1.76 ( 0.476%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

HSDT Performance

Trading levels for HSDT

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 1.82 4.19%
R2 1.80 2.77%
R1 1.78 1.90%
Price 1.75
S1 1.73 -0.94%
S2 1.72 -1.82%
S3 1.69 -3.24%

Accumulated Volume Support & Resistance Levels

Level Price
R3 2.16 23.43%
R2 2.12 21.14%
R1 1.98 13.14%
Price 1.75
S1 1.60 -8.57%
S2 1.51 -13.71%
S3 1.48 -15.43%

FAQ

What is the symbol for Helius Medical Technologies, Inc. Stock and on which exchange is it traded?
The symbol for Helius Medical Technologies, Inc. is HSDT and it is traded on the OTCMKTS (OTC Markets Group).

Should I buy or sell Helius Medical Technologies, Inc. Stock?
Helius Medical Technologies, Inc. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Sell candidate.

How to buy Helius Medical Technologies, Inc. Stock?
Helius Medical Technologies, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Helius Medical Technologies, Inc. Stock.

What's the current price of Helius Medical Technologies, Inc. Stock?
As of the end of day on the Jul 10, 2026, the price of an Helius Medical Technologies, Inc. (HSDT) share was $1.75.

What is the 52-week high and low for Helius Medical Technologies, Inc. Stock?
The 52-week high for Helius Medical Technologies, Inc. Stock is $25.50 and the 52-week low is $1.19.

What is the market capitalization of Helius Medical Technologies, Inc. Stock?
As of the Jul 10, 2026, the market capitalization of Helius Medical Technologies, Inc. is 102.177M.

When is the next earnings date for Helius Medical Technologies, Inc.?
The upcoming earnings date for Helius Medical Technologies, Inc. is Aug 13, 2026.
Click to get the best stock tips daily for free!
ABOUT HELIUS MEDICAL TECHNOLOGIES, INC.
Helius Medical Technologies
Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-invasive technologies for the treatment of symptoms caused by neurological disease or trauma. Its product, Portable Neuromodulation Stimulator (PoNS), is a non-surgical medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic...
GOLDEN STAR
Ticker Change Signal Date
SRPT
$17.02
11.34% Jun 29
NMRK
$15.02
1.20% Jun 24
NESR
$25.07
14.16% Jun 23
CAG
$13.43
2.98% Jun 23
GIB
$66.69
0.555% Jun 12

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE